Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hippocampus | 10 | 2017 | 280 | 1.530 |
Why?
|
| Epilepsy, Temporal Lobe | 5 | 2023 | 50 | 1.090 |
Why?
|
| Electroencephalography | 4 | 2024 | 136 | 1.050 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2023 | 1311 | 0.830 |
Why?
|
| Memory Disorders | 2 | 2017 | 177 | 0.610 |
Why?
|
| Neural Pathways | 1 | 2017 | 83 | 0.570 |
Why?
|
| Alzheimer Disease | 6 | 2019 | 2132 | 0.480 |
Why?
|
| Temporal Lobe | 3 | 2023 | 103 | 0.470 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2011 | 40 | 0.460 |
Why?
|
| Epilepsy | 3 | 2018 | 107 | 0.400 |
Why?
|
| White Matter | 1 | 2014 | 157 | 0.400 |
Why?
|
| Parahippocampal Gyrus | 1 | 2011 | 7 | 0.380 |
Why?
|
| Amnesia | 2 | 2011 | 29 | 0.360 |
Why?
|
| Drug Resistant Epilepsy | 2 | 2023 | 19 | 0.340 |
Why?
|
| Brain Mapping | 5 | 2016 | 190 | 0.340 |
Why?
|
| Atrophy | 5 | 2014 | 100 | 0.300 |
Why?
|
| Organ Size | 6 | 2014 | 107 | 0.290 |
Why?
|
| Entorhinal Cortex | 4 | 2012 | 36 | 0.280 |
Why?
|
| Nerve Fibers | 1 | 2006 | 14 | 0.270 |
Why?
|
| Aging | 4 | 2018 | 1727 | 0.250 |
Why?
|
| Cerebral Cortex | 2 | 2017 | 195 | 0.240 |
Why?
|
| Memory | 4 | 2011 | 328 | 0.240 |
Why?
|
| Humans | 21 | 2024 | 30994 | 0.240 |
Why?
|
| Female | 18 | 2018 | 16980 | 0.230 |
Why?
|
| Male | 15 | 2018 | 16442 | 0.220 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 3 | 2018 | 17 | 0.200 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 2 | 2012 | 6 | 0.200 |
Why?
|
| Potassium Channels | 2 | 2012 | 45 | 0.190 |
Why?
|
| Neuroimaging | 3 | 2018 | 144 | 0.180 |
Why?
|
| Membrane Proteins | 2 | 2012 | 184 | 0.180 |
Why?
|
| Aged | 11 | 2018 | 10045 | 0.170 |
Why?
|
| Channelopathies | 1 | 2018 | 7 | 0.160 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2018 | 17 | 0.150 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 43 | 0.150 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 44 | 0.150 |
Why?
|
| Neurology | 1 | 2019 | 79 | 0.150 |
Why?
|
| Pyramidal Cells | 1 | 2018 | 44 | 0.150 |
Why?
|
| Adult | 6 | 2017 | 8929 | 0.140 |
Why?
|
| Magnetoencephalography | 1 | 2017 | 4 | 0.140 |
Why?
|
| Brain Waves | 1 | 2016 | 7 | 0.140 |
Why?
|
| Electric Stimulation | 1 | 2016 | 83 | 0.140 |
Why?
|
| Young Adult | 5 | 2016 | 2063 | 0.130 |
Why?
|
| Brain | 3 | 2011 | 1801 | 0.130 |
Why?
|
| Functional Laterality | 4 | 2014 | 88 | 0.130 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2016 | 62 | 0.130 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 81 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2018 | 1921 | 0.120 |
Why?
|
| Neurosurgical Procedures | 1 | 2016 | 162 | 0.110 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 225 | 0.110 |
Why?
|
| Risk | 1 | 2014 | 221 | 0.110 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 5189 | 0.100 |
Why?
|
| Perforant Pathway | 1 | 2012 | 5 | 0.100 |
Why?
|
| Axons | 1 | 2012 | 37 | 0.100 |
Why?
|
| Protein Subunits | 1 | 2011 | 21 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2011 | 43 | 0.090 |
Why?
|
| Positron-Emission Tomography | 2 | 2010 | 98 | 0.090 |
Why?
|
| Headache | 1 | 2011 | 43 | 0.090 |
Why?
|
| Middle Aged | 9 | 2018 | 10192 | 0.090 |
Why?
|
| Implantable Neurostimulators | 1 | 2010 | 15 | 0.090 |
Why?
|
| Biomarkers | 1 | 2014 | 733 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2018 | 2042 | 0.090 |
Why?
|
| Seizures | 2 | 2023 | 94 | 0.090 |
Why?
|
| Frontal Lobe | 2 | 2011 | 83 | 0.090 |
Why?
|
| Analgesia, Epidural | 1 | 2007 | 59 | 0.070 |
Why?
|
| Neoplasms | 1 | 2010 | 260 | 0.070 |
Why?
|
| Verbal Learning | 2 | 2005 | 39 | 0.070 |
Why?
|
| Pain | 1 | 2010 | 426 | 0.070 |
Why?
|
| Depression | 1 | 2011 | 481 | 0.070 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 1504 | 0.070 |
Why?
|
| Dementia | 1 | 2012 | 560 | 0.070 |
Why?
|
| Pain Measurement | 1 | 2007 | 489 | 0.060 |
Why?
|
| Cognition | 1 | 2014 | 1427 | 0.060 |
Why?
|
| Adolescent | 3 | 2016 | 2401 | 0.060 |
Why?
|
| Pain, Postoperative | 1 | 2007 | 334 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2011 | 1055 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2018 | 3656 | 0.060 |
Why?
|
| Proof of Concept Study | 1 | 2023 | 14 | 0.050 |
Why?
|
| Parkinson Disease | 1 | 2012 | 1069 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2018 | 3806 | 0.050 |
Why?
|
| Child | 2 | 2016 | 1429 | 0.050 |
Why?
|
| Peroxins | 2 | 2012 | 5 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2016 | 549 | 0.050 |
Why?
|
| Protein Transport | 2 | 2012 | 40 | 0.050 |
Why?
|
| Animals | 3 | 2018 | 4722 | 0.050 |
Why?
|
| Algorithms | 1 | 2023 | 414 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2012 | 466 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2019 | 35 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2019 | 70 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 27 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 261 | 0.040 |
Why?
|
| Action Potentials | 1 | 2018 | 144 | 0.040 |
Why?
|
| Malformations of Cortical Development, Group I | 1 | 2017 | 2 | 0.040 |
Why?
|
| Sensory Thresholds | 1 | 2016 | 23 | 0.030 |
Why?
|
| Mice | 2 | 2012 | 1682 | 0.030 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2017 | 81 | 0.030 |
Why?
|
| Age Factors | 1 | 2018 | 873 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2016 | 144 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 781 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 689 | 0.030 |
Why?
|
| Reference Values | 2 | 2005 | 229 | 0.030 |
Why?
|
| Internet | 1 | 2014 | 92 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 230 | 0.030 |
Why?
|
| Tissue Embedding | 1 | 2012 | 5 | 0.030 |
Why?
|
| Dentate Gyrus | 1 | 2012 | 8 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2012 | 16 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 34 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2012 | 45 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2012 | 55 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 818 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 126 | 0.020 |
Why?
|
| Valproic Acid | 1 | 2011 | 30 | 0.020 |
Why?
|
| Sclerosis | 1 | 2011 | 71 | 0.020 |
Why?
|
| Age of Onset | 1 | 2011 | 111 | 0.020 |
Why?
|
| Radioisotopes | 1 | 2010 | 13 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2011 | 93 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 685 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2011 | 322 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2011 | 112 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2010 | 46 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 335 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 873 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2010 | 85 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 243 | 0.020 |
Why?
|
| Educational Status | 1 | 2011 | 312 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 829 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2010 | 532 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 1009 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2012 | 1316 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1133 | 0.020 |
Why?
|
| Incidence | 1 | 2007 | 785 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2003 | 116 | 0.010 |
Why?
|